Emergingby GlyphFDA clears Motif's depression BCI for a first clinical trial
Motif's wireless DOT implant gets approval for an early feasibility study in treatment-resistant depression.
Brain-computer interfacesnews.rice.edu
Motif Neurotech
StartupUS1 field
Where it works
| Technology | ||
|---|---|---|
| Brain-computer interfacesDevelops DOT, a small wireless implant that stimulates brain circuits to treat depression. | Develops DOT, a small wireless implant that stimulates brain circuits to treat depression. | motifneuro.tech |
Events
About
- Source
- motifneuro.tech (official, added by seed)
- First seen
- Sep 25, 2026
- Last seen
- Oct 6, 2026
- Across Glyph
- Motif Neurotech on Companies